Cytokinetics

Cytokinetics, Incorporated
	Headquarters in South San Francisco
Company type	Public
Traded as	Nasdaq: CYTK; S&P 400 component;
Industry	Biotechnology industry
Founded	1997
Founders	James Spudich; Ronald Vale; James Sabry; Lawrence S.B. Goldstein;
Headquarters	South San Francisco, California, U.S.
Key people	Robert Blum (president & CEO); Fady Malik (EVP); Ching Jaw (CFO); Stuart Kupfer (CMO);
Products	Omecamtiv mecarbil; Reldesemtiv; CK-3773274;
Revenue	US$7.53 million (2023)
Operating income	US$(496.2 million) (2023)
Net income	US$(526.2 million) (2023)
Total assets	US$824.3 million (2023)
Number of employees	423 (December 2023)
Website	cytokinetics.com
	Footnotes / references; Financials as of December 31, 2023.

Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.